Kyowa Hakko Articles
Stock Commentary - Week to Feb 17 - Tokyo
24 February 2003
Japan's Kyowa Hakko sets up US antibody business
24 February 2003
Japanese drugmakers increase drug side effect monitoring
3 February 2003
Tokyo pharma stocks - week to July 8
15 July 2002
Japanese firms reward drug research results
8 July 2002
Kyowa starts Ph II trial of MAb for melanoma
24 June 2002
Tokyo pharma stocks - week to April 8
15 April 2002
Kyowa Hakko lowers earnings forecasts
8 April 2002
Eisai expanding ties with rest of Asia
1 April 2002
Tokyo pharma stocks - week to March 18
25 March 2002
Tokyo stocks to March 11
18 March 2002
High hopes for Japanese biotech, says Nikkei survey
4 March 2002
Tokyo pharma stocks - week to February 25
4 March 2002
Tokyo pharma stocks - week to February 18
25 February 2002
Kyowa says Parkinson's drug trials are promising
25 February 2002
Tokyo pharma stocks - week to January 7
14 January 2002
Kyowa Hakko unveils new Ab production tech
7 January 2002
Kyowa Hakko unveils new Ab production tech
28 December 2001
Tokyo pharma stocks - week to December 10
11 December 2001
Pharma sales down at Kyowa Hakko
28 November 2001
Stock Commentary - Tokyo
1 November 2001
Tokyo pharma stocks - week to October 29
30 October 2001
J&J to take full control of Janssen-Kyowa JV
26 October 2001
Japanese approvals for GSK and Janssen-Kyowa
9 October 2001
Japanese pharma stocks - week to September 24
26 September 2001
Japan pharma stocks - week to July 23
25 July 2001
Kyowa Hakko signs database deal
20 July 2001
Stock Commentary - Tokyo
19 July 2001
Japan pharma stocks - week to July 16
18 July 2001
Japan pharma stocks - week to July 9
11 July 2001
Japan pharma stock market, week to June 25
27 June 2001
Tokyo stock comment
12 June 2001
Tokyo pharma stocks week to April 30
2 May 2001
Stock Commentary - Tokyo
19 April 2001
Tokyo pharma stock market week to April 16
18 April 2001
France clears oral form of vinorelbine
5 April 2001
Pharmagene slides on revenues delay
30 November 2000
UPDATE - Scotia crashes on FDA "not approvable" verdict for Foscan
27 September 2000
Stock Commentary Tokyo
15 June 2000
Japan to test t-PA in stroke?
27 April 2000
Sankyo link-up with Kyowa Hakko for NK-104?
11 April 2000
Stock Commentary Tokyo
3 April 2000
Stock Commentary Tokyo
16 March 2000
Stock Commentary Tokyo
2 March 2000
Stock Commentary Tokyo
17 February 2000
Stock Commentary Tokyo
20 January 2000
Stock Commentary Tokyo
13 January 2000
Stock Commentary Tokyo
28 October 1999
Japan's drugmakers will have to "globalize"
10 September 1999
New president at Mohan Medical
22 July 1999
Lundbeck fills pipeline, signs CNS deals
1 June 1999
Kyowa rationalises US activities
11 February 1999
Stock Commentary Tokyo
20 January 1999
Kyowa Hakko Expanding Overseas
11 December 1998
Stock Commentary Tokyo
3 December 1998
Boeh Ingelheim Pulls Out Of Foscan Deal With Scotia
27 November 1998
Stock Commentary Tokyo
10 September 1998
Roche Ends Kyowa Hakko Collaboration
2 September 1998
LeukoSite Raises $11.8 Million In Placement
9 July 1998
Marketing Deal For Cephalon Drugs
30 June 1998
LeukoSite Lead Product May Be On Market By 2000
28 May 1998
Japan's Drugmakers Shifting Development
8 May 1998
Kyowa Hakko Extends Deal With LeukoSite
14 April 1998
Kyowa Hakko Merges Generic Units
31 March 1998
B-MS And UT Austin Link-Up For Telomerase Research
20 March 1998
Top Firms Maintaining Strong Sales & Profits
13 January 1998
Chemokine Collaboration: LeukoSite, W-L and Kyowa Hakko
20 November 1997
Disappointing 1st Half For Kyowa Hakko
3 November 1997
Stock Commentary Tokyo
30 October 1997
Scotia "Transformation" Points To Rosier Future
25 September 1997
Scotia Sells Rights To Foscan For $54m
17 September 1997
US Drug & Biotech Firms Post Quarterly Results
14 August 1997
Tokyo Stock Comment
7 August 1997
Tokyo Stock Comment
19 June 1997
Tokyo Stock Comment
26 May 1997
Cephalon 1st-Qtr Loss Increases
26 May 1997
Tokyo Stock Comment
19 May 1997
P&U And Geron In Cancer Collaboration
7 April 1997
Interim Financial Results From The USA
18 November 1996
Appointment At Kyowa Hakko
28 October 1996
TOKYO STOCK COMMENT
29 July 1996
Higher-Priced Drugs Set To Expand Epilepsy Market
12 February 1996
Sustainability Key To Biotech In Strong 2nd Qtr
17 July 1995
Cephalon's Myotrophin Clears Major Hurdle
19 June 1995
Geron And Kyowa Forge Cancer Pact
22 May 1995
Higher Sales Boost Profits At Kyowa Hakko
3 April 1995
Tokyo STOCK COMMENT
20 March 1995
Slower Growth For Chugai Forecast
20 March 1995
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
